BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

Search

Gerresheimer AG

Gesloten

SectorGezondheidszorg

55.3 2.88

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

52.85

Max

55.65

Belangrijke statistieken

By Trading Economics

Inkomsten

-56M

-17M

Verkoop

-49M

520M

K/W

Sectorgemiddelde

22.741

57.333

EPS

0.46

Dividendrendement

2.41

Winstmarge

-3.363

Werknemers

13,632

EBITDA

-33M

84M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+83.02% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.41%

2.63%

Volgende Winsten

10 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-40M

1.8B

Vorige openingsprijs

52.42

Vorige sluitingsprijs

55.3

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Gerresheimer AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 apr 2025, 10:15 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 apr 2025, 09:39 UTC

Acquisities, Fusies, Overnames

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

13 mei 2024, 11:16 UTC

Top Nieuws

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Peer Vergelijking

Prijswijziging

Gerresheimer AG Prognose

Koersdoel

By TipRanks

83.02% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 98.1 EUR  83.02%

Hoogste 122.5 EUR

Laagste 84.5 EUR

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Gerresheimer AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technische score

By Trading Central

53.05 / 53.85Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Neutral Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.